Effect of calcium antagonists on glomerular arterioles in spontaneously hypertensive rats

Hypertension

Volumn 35, Issue 3, 2000, Pages 775-779

  Sabbatini, Maurizio ^a   Leonardi, Amedeo ^b   Testa, Rodolfo ^b   Vitaioli, Lucia ^a   Amenta, Francesco ^a,c  

^a UNIVERSITY OF CAMERINO   (Italy)

^b Recordati SpA   (Italy)

^c Dipto Sci Farmacologiche Med S   (Italy)

Author keywords

Arterioles; Calcium antagonists; Rats, SHR

Indexed keywords

CALCIUM ANTAGONIST; DIHYDROPYRIDINE DERIVATIVE; HYDRALAZINE; LERCANIDIPINE; MANIDIPINE; NICARDIPINE; VASODILATOR AGENT;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CALCIUM ANTAGONISM; CONTROLLED STUDY; DRUG EFFICACY; GLOMERULOSCLEROSIS; GLOMERULUS; HYPERTENSION; KIDNEY DISEASE; MALE; MESANGIUM CELL; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

EID: 0034063529     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.3.775     Document Type: Article

References (25)

1. Boyd W. Pathology, Structure, and Function in Disease, 8th ed. Philadelphia, Pa: Lea & Febiger; 1970.
2. Saito N, Mukaino S. Renal tissue lesions in spontaneously hypertensive rats. Jpn Heart J. 1979;20:694-698.
3. Feld LG, Van Liew JB, Galaske RG, Boylan JW. Selectivity of renal injury and proteinuria in spontaneously hypertensive rat. Kidney Int. 1977;12:332-343.
4. Dworkin LD, Feiner HD. Glomerular injury in uninephrectomized spontaneously hypertensive rats: a consequence of glomerular capillary hypertension. J Clin Invest. 1986;77:797-809.
5. Martinez-Maldonado M, Rodriguez-Sargent C, Cangiano JL, Dworkin LD. Pathogenesis of systemic hypertension and glomerular injury in the spontaneously hypertensive rat. Am J Cardiol. 1987;60:471-521.
6. Dworkin LD, Tolbert E, Recht PA, Hersch JC, Feiner H, Levin R. Effects of amlodipine on glomerular filtration, growth, and injury in experimental hypertension. Hypertension. 1996;27:245-250.
7. Hayashi K, Nagahama T, Oka K, Epstain M, Saruta T. Disparate effects of calcium antagonists on renal microcirculation. Hypertens Res. 1996; 19:31-36.
8. Ozawa Y, Hayashi K, Nagahama T, Fujiwara K, Wakino S, Saruta T. Renal afferent and efferent arteriolar dilatation by nivaldipine: studies in the isolated perfused hydronephrotic kidney. J Cardiovasc Pharmacol. 1999;33:243-247.
9. Nayler WJ. Calcium Antagonists. Sidney/London/New York: Academic Press; 1985.
10. Fleming JT, Parekh N, Steinhausen M. Calcium antagonists preferentially dilate preglomerular vessels of hydronephrotic kidney. Am J Physiol. 1987;253:F1157-F1163.
11. Tojo A, Kimura K, Matsuoka H, Sugimoto T. Effects of manidipine hydrochloride on the renal microcirculation in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1992;20:895-899.
12. Testa R, Leonardi A, Tajana A, Riscassi E, Magliocca R, Sartani A. Lercanidipine (REC 15/2375): a novel 1.4 dihydropyridine calcium antagonist for hypertension. Cardiovasc Drugs Res. 1997;15:187-219.
13. Ferrante F, Abbate F, Ciriaco E, Polidori C, Amenta F. Protective effect of nicardipine treatment on renal microanatomical changes in spontaneously hypertensive rats. Clin Exp Hypertens. 1994;16:415-429.
14. Allison MEM, Lipham EM, Gottschalk CW. Hydrostatic pressure in the rat kidney. Am J Physiol. 1972;223:975-983.
15. Hostetter TH, Rennke HG, Brenner BM. The calcium antagonists for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Physiol. 1982;72:375-380.
16. Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest. 1986;77:1993-2000.
17. Wenzel UO, Helmchen U, Schoeppe W, Schwietzer G. Combination treatment of enalapril with nitrendipine in rats with renovascular hypertension. Hypertension. 1994;23:114-122.
18. Lazarus J, Hampers CL, Merill JP. Hypertension in chronic renal failure: treatment with hemodialysis and nephrectomy. Arch Intern Med. 1974; 133:1059-1066.
19. Loutzenhiser R, Hayashi K, Epstain M. CA augment glomerular filtration rate of angiotensin II-vasoconstricted isolated perfused rat kidneys by dilating afferent but not efferent arterioles. J Cardiovasc Pharmacol. 1988;12(suppl 6):s-149-s-154.
20. Dworkin LD, Benstein JA, Parker M, Tolbert E, Feiner HD. Calcium antagonisis and converting enzyme inhibitors reduce renal injury by different mechanisms. Kidney Int. 1993;43:808-814.
21. Sironi G, Colombo D, Greto L, Leonardi A, Testa R. Regional vasodilating effect of lercanidipine in dogs. J Mol Cell Cardiol. 1998;30:A193.
22. Tojo A, Kimura K, Nanba S, Matsuoka K. Variations of renal arteriolar diameter in deoxycorticosterone acetate-sall hypertensive rats: a microvascular study. Virchows Arch [A] Pathol Anat Histopathol. 1990;417: 389-393.
23. Kimura K, Tojo A, Matsuoka H, Sugimoto T. Renal arteriolar diameters in spontaneously hypertensive rats: vascular cast study. Hypertension. 1991;18:101-110.
24. Heagerty AM, Aalkjaer C, Bound SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension: dual process of remodeling and growth. Hypertension. 1993;21:391-397.
25. Baumbach GL, Heistad DD. Remodeling of cerebral arterioles in chronic hypertension. Hypertension. 1989;13:968-972.